Johannes Jacob Pieter Kastelein - 07 Jan 2025 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role: Chief Scientific Officer, Director
Signature: /s/ Louise Kooij by Power of Attorney from Johannes Jacob Pieter Kastelein
Issuer symbol: NAMS
Transactions as of: 07 Jan 2025
Transactions value $: $0
Form type: 4
Filing time: 07 Jan 2025, 17:21:06 UTC
Previous filing: 06 Jan 2025
Next filing: 26 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NAMS	Ordinary Shares	Award		+34K			34K	07 Jan 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units (RSUs), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
F2	Each RSU was granted on January 7, 2025 for no consideration.